| Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy I Riquelme, K Saavedra, JA Espinoza, H Weber, P García, B Nervi, ... Oncotarget 6 (28), 24750, 2015 | 159 | 2015 |
| miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway I Riquelme, O Tapia, P Leal, A Sandoval, MG Varga, P Letelier, ... Cellular oncology 39, 23-33, 2016 | 145 | 2016 |
| The inflammatory inception of gallbladder cancer JA Espinoza, C Bizama, P García, C Ferreccio, M Javle, JF Miquel, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1865 (2), 245-254, 2016 | 139 | 2016 |
| The gene expression status of the PI3K/AKT/mTOR pathway in gastric cancer tissues and cell lines I Riquelme, O Tapia, JA Espinoza, P Leal, K Buchegger, A Sandoval, ... Pathology & Oncology Research 22, 797-805, 2016 | 110 | 2016 |
| MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer A Sandoval-Bórquez, I Polakovicova, N Carrasco-Véliz, ... Clinical epigenetics 9, 1-16, 2017 | 74 | 2017 |
| Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy C Bizama, P García, JA Espinoza, H Weber, P Leal, B Nervi, JC Roa Cancer Treatment Reviews 41 (3), 222-234, 2015 | 73 | 2015 |
| Mutación del gen BRAF en pacientes con cánceres de colon y recto con KRAS no mutado I Roa, A Game, C Bizama, K Schalper Revista médica de Chile 142 (1), 55-60, 2014 | 68 | 2014 |
| Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate A Pandey, EW Stawiski, S Durinck, H Gowda, LD Goldstein, ... Nature communications 11 (1), 4225, 2020 | 58 | 2020 |
| IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without … J Bayo, A Real, EJ Fiore, M Malvicini, L Sganga, M Bolontrade, O Andriani, ... Oncotarget 8 (46), 80235, 2017 | 52 | 2017 |
| Simvastatin interferes with cancer ‘stem-cell’plasticity reducing metastasis in ovarian cancer S Kato, MF Liberona, J Cerda-Infante, M Sánchez, J Henríquez, C Bizama, ... Endocrine-Related Cancer 25 (10), 821-836, 2018 | 41 | 2018 |
| The low‐abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer C Bizama, F Benavente, E Salvatierra, A Gutiérrez‐Moraga, JA Espinoza, ... International journal of cancer 134 (4), 755-764, 2014 | 38 | 2014 |
| Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets JI Erices, C Bizama, I Niechi, D Uribe, A Rosales, K Fabres, ... International journal of molecular sciences 24 (8), 7047, 2023 | 37 | 2023 |
| Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer H Weber, JR Valbuena, MA Barbhuiya, S Stein, H Kunkel, P García, ... Oncotarget 8 (16), 26169, 2017 | 29 | 2017 |
| Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer P García, L Rosa, S Vargas, H Weber, JA Espinoza, F Suárez, ... Cancers 12 (4), 778, 2020 | 24 | 2020 |
| Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy‐naïve pT2 gallbladder adenocarcinoma patients JA Espinoza, P García, C Bizama, JL Leal, I Riquelme, H Weber, ... Histopathology 68 (5), 722-728, 2016 | 19 | 2016 |
| Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice H Weber, P Leal, S Stein, H Kunkel, P García, C Bizama, JA Espinoza, ... Oncotarget 6 (31), 31877, 2015 | 19 | 2015 |
| Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma JA Espinoza, I Riquelme, EA Sagredo, L Rosa, P García, C Bizama, ... Histopathology 74 (4), 597-607, 2019 | 16 | 2019 |
| Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia L Rosa, L Lobos‐González, N Muñoz‐Durango, P García, C Bizama, ... Molecular Oncology 14 (11), 2834-2852, 2020 | 11 | 2020 |
| Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America M Salvo, E González-Feliú, J Toro, I Gallegos, I Maureira, ... Journal of Personalized Medicine 11 (9), 899, 2021 | 8 | 2021 |
| Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor P García, C Bizama, L Rosa, JA Espinoza, H Weber, J Cerda-Infante, ... Biological Research 53, 1-17, 2020 | 5 | 2020 |
JUAN CARLOS ROAPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Professor and Chair Department of Pathology.Verified email at med.puc.cl
